Substance / Medication

Cefoperazone sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Case Report: Anaphylactic shock induced by cefoperazone sodium and sulbactam sodium for injection.
Liu Weiqian, Gao Bo, Xie Shaowei et al. · Front Med (Lausanne) · 2025
PMID: 40606454Case ReportFull text (PMC)
Toxic epidermal necrolysis following heart transplantation may caused by cefoperazone sodium and sulbactam sodium.
Xiaodong Zeng, Min Wu, Liming Lei et al. · J Cardiothorac Surg · 2024
PMID: 39307887Case ReportFull text (PMC)
Predictive Analysis of Coagulation Dysfunction in Elderly Patients Caused by Cefoperazone Sodium-Sulbactam Sodium Use.
Li Man-Gui, Zeng Yuan-Hong, Xie Cheng-Juan et al. · Ann Clin Lab Sci · 2025
PMID: 40962465Other
Retracted: Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-ResistantPneumonia.
And Alternative Medicine Evidence-Based Complementary · Evid Based Complement Alternat Med · 2023
PMID: 38125170OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefoperazone sodium (substance)
SNOMED CT
3136005
UMLS CUI
C0733367

Clinical Data

This intervention maps to 16 entities in the Healos knowledge graph.

16
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.